BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.32.0//EN
X-ORIGINAL-URL:https://oligotherapeutics.org/
X-WR-CALNAME:Oligonucleotide Therapeutics Society
X-WR-CALDESC:Oligonucleotide Therapeutics Society
X-WR-TIMEZONE:UTC
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260514T164116
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-4d044b9de211f5db6b31938af4e5f46d@oligotherapeutics.org
DTSTART;TZID=UTC:20240523T170000
DTEND;TZID=UTC:20240523T180000
DTSTAMP:20240414T043611Z
CREATED:20240414
LAST-MODIFIED:20240414
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:Antisense approaches for the treatment of Duchenne muscular dystrophy and recent advances to address DMD brain comorbidities
DESCRIPTION:
URL:http://oligotherapeutics.org/antisense-approaches-for-the-treatment-of-duchenne-muscular-dystrophy-and-recent-advances-to-address-dmd-brain-comorbidities/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/webp:https://oligotherapeutics.org/wp-content/uploads/2024/04/05-23-2024.webp
END:VEVENT
END:VCALENDAR